Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
H
106190
vs
K
KOSPI 200
Over the past 12 months, High Tech Pharm Co Ltd has underperformed KOSPI 200, delivering a return of -21% compared to KOSPI 200's +125% growth.
Stocks Performance
106190 vs KOSPI 200
Performance Gap
106190 vs KOSPI 200
Performance By Year
106190 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
High Tech Pharm Co Ltd
Glance View
High Tech Pharm is a South Korean pharmaceutical company that makes and sells medicines and related healthcare products. Its business is centered on developing, manufacturing, and supplying drug products that are sold through pharmacies, hospitals, and other medical channels. In plain terms, it sits in the middle of the drug supply chain: it turns pharmaceutical ingredients and formulations into finished products that doctors, pharmacists, and patients can use. The company makes money mainly by selling those finished medicines and any related pharmaceutical products it supplies to the market. Like other drug makers, it depends on product sales rather than service fees, so demand comes from patient need, doctor prescriptions, and pharmacy stocking decisions. Its role is different from a drug distributor because it is involved in the actual production and formulation of medicines, not just moving boxes from one place to another. For beginner investors, the key point is that High Tech Pharm is a product-based healthcare business tied to the steady, recurring demand for medicines. Its fortunes depend on whether it can keep its products approved, trusted, and widely used by medical customers and consumers. That makes it a classic pharma manufacturer: regulated, product-focused, and closely linked to the healthcare system.